Trial intelligence / Profile preview

Uniform Multidrug Therapy (U-MDT) for Leprosy

NCT00669643Phase 4Completed

Sponsor
University of Brasília
Start
Feb 2007
Primary completion
Sep 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of rifampicin, clofazimine, dapsone in leprosy (HD), sponsored by University of Brasília. Started Feb 2007; status: completed.

02

Drugs

rifampicinclofaziminedapsone
03

Conditions

leprosy (HD)

Beyond the preview

Go deeper on NCT00669643.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00669643.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call